4/A//SEC Filing
HEMISPHERX BIOPHARMA INC 4/A
Accession 0001613377-17-000011
$AIMCIK 0000946644operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 12:26 PM ET
Size
5.3 KB
Accession
0001613377-17-000011
Insider Transaction Report
Form 4/AAmended
Pascale Adam
Chief Accounting Officer
Transactions
- Award
Options to buy Common Stock
2017-06-15$0.44/sh+4,738$2,085→ 4,738 totalExercise: $0.49From: 2017-06-15Exp: 2027-06-15→ Common Stock (4,738 underlying)
Footnotes (1)
- [F1]Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017.
Documents
Issuer
HEMISPHERX BIOPHARMA INC
CIK 0000946644
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000946644
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 12:26 PM ET
- Size
- 5.3 KB